As the novel coronavirus outbreak continues to evolve, Rush University and Rush University Medical Center have put in place guidelines for our research community to help aid in containing the spread of the virus while avoiding compromising sponsored projects and laboratory studies.

September 29, 2020

Rush Researchers:

Because of the changing nature of the COVID19 pandemic, guidance on research activity has been a moving target. Nevertheless, we encourage students, faculty, staff, and outside personnel (e.g. study monitors, users of core facilities, other collaborators) to conduct research under conditions that provide for their safety as well as the safety of patients and the public. This means that if students, faculty, staff, or outside personnel (e.g. study monitors, users of core facilities, other collaborators) have traveled to states covered by the most recent CDPH order, they must quarantine for 14 days and be symptom negative prior to coming to Rush facilities.

Additionally, all personnel should abide by the most recent CDPH guidelines and may conduct research under the following conditions:

  • All personnel must participate in universal masking. Rush will provide the mask to be worn on campus.
  • All personnel must participate in social distancing.
  • All personnel should self-screen prior to entering Rush campus for signs or symptoms of COVID (COVID-19 self-assessment). If any signs/symptoms are present researchers may not come onto campus (Health and Testing).
  • All personnel should coordinate days/times spent in research labs/clinics with PIs or their designees. This will help to minimize the density of researchers in the research environment to protect the well-being of other researchers.
  • All personnel must enter campus through designated entry points, at which they will be temperature screened, and will be given a Rush approved face mask that must be worn at all times while on campus. If any person does not pass this screening satisfactorily, Rush-affiliated personnel should follow appropriate procedures outlined (FAQ).
  • There may be restrictions or areas of the campus or clinics where personnel may not visit. Please check with Rush personnel for area-specific instructions.
  • For the safety of all staff, patients, monitors, and the public, please limit the time and duration of laboratory or clinic time to only the time required. Any part of a project/study that can be done remotely or in an alternate manner should be explored.

Kind regards,
Andrew Bean, PhD
Crista Brawley, PhD
Raj Shah, MD

July 6, 2020

  • The Chicago Department of Public Health (CDPH) issued an Emergency Travel Order  starting on Monday, July 6, 2020 until further notice. We have therefore modified our guidance to study monitors for clinical research projects to follow the CDPH guidelines. If personnel have traveled to states covered by the order they must quarantine and be symptom negative prior to coming to the Rush campus in Chicago. Please see the document below for more information.

June 2, 2020

May 18, 2020

  • In an effort to proactively plan for the safe re-entry of researchers into the clinical and laboratory settings at Rush, two sets of guidelines have been developed. The first is focused on laboratory research and was developed by the Laboratory Research Normalization Task Force, chaired by Anne-Marie Malfait, MD, PhD; and the second is focused on clinical research and was developed by the Clinical Research Normalization Task Force, chaired by Niranjan Karnik, MD, PhD.
  • We will follow a phased re-opening model as described in the attached plans. Please recognize that the State and City shelter-in-place order is in effect until May 29, 2020. For the next two weeks, prior to lifting of the stay-at-home order, we will continue to procure required items (PPE, signage, hand sanitizer and disinfectant), and prepare buildings for the safe continuation of research activities. The Laboratory Research Normalization Task Force developed scheduling tools to help implement measures that will enable social distancing and promote safety for all personnel.

March 18, 2020

  • We have prepared a list of Research FAQs to address issues relating to the conduct of clinical investigation, operations, sponsored projects and laboratory studies during this pandemic.
    This document is subject to change as new information is received and new government regulations are introduced. Please review the document and continue to check for updates on research procedures.
  • We have created a hub for all clinical and non-clinical coronavirus research at Rush, as well as links to access COVID-19 scientific literature and clinical trials around the world. Visit COVID-19 Science for the latest news.